Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-01-12 @ 7:56 AM
Study NCT ID:
NCT01107405
Status:
COMPLETED
Last Update Posted:
2012-03-21
First Post:
2010-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
Sponsor:
Bausch & Lomb Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-15
First Submit QC Date:
None
Study First Post Date:
2010-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-21
Results First Submit QC Date:
None
Results First Post Date:
2012-03-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-14
Last Update Post Date:
2012-03-21
Last Update Post Date Type:
ESTIMATED